HomeNewsBusinessAirports are congested, but traffic isn’t at pre-Covid levels. What gives?

Airports are congested, but traffic isn’t at pre-Covid levels. What gives?

 After reports of Omicron emerged, the regulator was quick to suspend international services till January. New guidelines have resulted in bottlenecks at immigration and customs at Delhi and Mumbai airports – the two gateways to India for international travellers

December 10, 2021 / 14:43 IST
Story continues below Advertisement
Representative image: AP
Representative image: AP

The past few days have seen a flurry of activity in the aviation sector. Within hours of the announcement that international services would open up from mid-December, reports of a new variant of the COVID-19 virus led to a rethink and eventual extension of the suspension.

The regulator was quick to extend the suspension until end of January. This was supplemented with guidelines from various ministries, implementation of rules like random testing at airports, mandatory arrival tests for passengers arriving from “high risk” countries, and more.

Story continues below Advertisement

This resultant bottlenecks led to an outpouring of pictures on social media showing the massive congestion at immigration, customs and other choke points at airports, primarily at Delhi and Mumbai, the two gateways for international flights in India.

International the new challenge

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show